Aaron Wexler, Ph.D.
Prior to joining the Skaar lab in 2018, Aaron received a B.S. in biology from Cornell University, and an M. Phil. and PhD in microbiology from Yale University. While in the Skaar lab, Aaron was awarded a Helen Hay Whitney Foundation postdoctoral fellowship to study how Clostridioides difficile invades and modifies the host intestinal environment. In 2021, he joined the vaccine research and development team at Pfizer as a senior manager of scientific communications.